United Therapeutics (UTHR) Intangibles (2011 - 2020)

United Therapeutics has disclosed Intangibles across 10 years of filings, most recently posting $128.9 million for Q1 2020.

• In Q1 2020, Intangibles fell 6.39% year-over-year to $128.9 million; the TTM figure through Mar 2020 stood at $128.9 million (down 6.39% YoY), while the FY2019 annual figure was $128.9 million, down 6.39% from the prior year.
• Intangibles came in at $128.9 million for Q1 2020 at United Therapeutics, roughly flat from $128.9 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $137.7 million in Q3 2018 to a low of $21.5 million in Q1 2016.
• Average Intangibles over 5 years is $75.2 million, with a median of $30.4 million recorded in 2017.
• Year-over-year, Intangibles jumped 352.96% in 2018 and fell 6.39% in 2019.
• Over 5 years, Intangibles stood at $21.5 million in 2016, then jumped by 41.4% to $30.4 million in 2017, then jumped by 352.96% to $137.7 million in 2018, then declined by 6.39% to $128.9 million in 2019, then changed by 0.0% to $128.9 million in 2020.
• Per Business Quant data, the three most recent Intangibles figures were $128.9 million in Q1 2020, $128.9 million in Q4 2019, and $128.9 million in Q3 2019.